Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does THYMOCYTE IMMUNE GLOBULIN NOS Cause Pathogen resistance? 48 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Pathogen resistance have been filed in association with THYMOCYTE IMMUNE GLOBULIN NOS. This represents 0.9% of all adverse event reports for THYMOCYTE IMMUNE GLOBULIN NOS.

48
Reports of Pathogen resistance with THYMOCYTE IMMUNE GLOBULIN NOS
0.9%
of all THYMOCYTE IMMUNE GLOBULIN NOS reports
15
Deaths
23
Hospitalizations

How Dangerous Is Pathogen resistance From THYMOCYTE IMMUNE GLOBULIN NOS?

Of the 48 reports, 15 (31.3%) resulted in death, 23 (47.9%) required hospitalization, and 2 (4.2%) were considered life-threatening.

Is Pathogen resistance Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for THYMOCYTE IMMUNE GLOBULIN NOS. However, 48 reports have been filed with the FAERS database.

What Other Side Effects Does THYMOCYTE IMMUNE GLOBULIN NOS Cause?

Off label use (749) Drug ineffective (692) Cytomegalovirus infection (404) Product use in unapproved indication (396) Transplant rejection (340) Post transplant lymphoproliferative disorder (319) Epstein-barr virus infection (255) Pneumonia (254) 503 Service Unavailable

Service Unavailable

The server is temporarily unable to service your request due to maintenance downtime or capacity problems. Please try again later.

Additionally, a 503 Service Unavailable error was encountered while trying to use an ErrorDocument to handle the request.